CD70 and hepatitis B virus infection: Whether the potential of CD70 co-expression in a therapeutic vaccination setting against hepatitis B is underestimated by the choice of the HBV core instead of the more potent HBV surface antigen as a model was not assessed and would be an interesting subject for further investigation.